Discontinued — last reported Q3 '23
Equity securities
Idexx Laboratories Equity securities decreased by 13.2% to $27.56M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.1%, from $31.00M to $27.56M. Over 2 years (FY 2023 to FY 2025), Equity securities shows relatively stable performance with a 2.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase reflects positive market performance of the underlying investments or additional capital deployment into equities.
Detailed definition
This represents the fair market value of the company's investment portfolio consisting of equity securities in other ent...
Peer comparison
Standard for companies with large corporate venture arms or significant treasury investment portfolios.
ins_equity_securitiesHistorical Data
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.25M | $30.00M | $30.00M | $30.00M | $31.00M | $31.00M | $31.00M | $31.76M | $31.76M | $27.56M |
| QoQ Change | — | -0.8% | +0.0% | +0.0% | +3.3% | +0.0% | +0.0% | +2.4% | +0.0% | -13.2% |
| YoY Change | — | — | — | — | +2.5% | +3.3% | +3.3% | +5.9% | +2.4% | -11.1% |
Equity securities at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's equity securities?
- Idexx Laboratories (IDXX) reported equity securities of $27.56M in Q1 2026.
- How has Idexx Laboratories's equity securities changed year-over-year?
- Idexx Laboratories's equity securities decreased by 11.1% year-over-year, from $31.00M to $27.56M.
- What is the long-term trend for Idexx Laboratories's equity securities?
- Over 2 years (2023 to 2025), Idexx Laboratories's equity securities has grown at a 2.5% compound annual growth rate (CAGR), from $30.25M to $31.76M.
- What does equity securities mean?
- The current market value of the company's stock investments in other businesses.